About Boston Scientific Corporation
Boston Scientific Corporation (BSX) has been publicly traded since 1992, making it a 34-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Marlborough, United States and employs approximately 59,000 people. With a market capitalization of $103 billion, BSX is a large established company.
Key Statistics
- Current Price
- $69.51
- Market Cap
- $103.14B
- 52-Week High
- $109.50
- 52-Week Low
- $67.56
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -27.10% | $95.35 | $69.51 |
| 2025 | +6.75% | $89.32 | $95.35 |
| 2024 | +54.51% | $57.81 | $89.32 |
| 2023 | +24.94% | $46.27 | $57.81 |
| 2022 | +8.92% | $42.48 | $46.27 |
| 2021 | +18.16% | $35.95 | $42.48 |
| 2020 | -20.50% | $45.22 | $35.95 |
| 2019 | +27.96% | $35.34 | $45.22 |
| 2018 | +42.56% | $24.79 | $35.34 |
| 2017 | +14.61% | $21.63 | $24.79 |
| 2016 | +17.30% | $18.44 | $21.63 |
| 2015 | +39.17% | $13.25 | $18.44 |
| 2014 | +10.23% | $12.02 | $13.25 |
| 2013 | +109.77% | $5.73 | $12.02 |
| 2012 | +7.30% | $5.34 | $5.73 |
| 2011 | -29.46% | $7.57 | $5.34 |
| 2010 | -15.89% | $9.00 | $7.57 |
| 2009 | +16.28% | $7.74 | $9.00 |
| 2008 | -33.45% | $11.63 | $7.74 |
| 2007 | -32.31% | $17.18 | $11.63 |
| 2006 | -29.85% | $24.49 | $17.18 |
| 2005 | -31.11% | $35.55 | $24.49 |
| 2004 | -3.29% | $36.76 | $35.55 |
| 2003 | +72.91% | $21.26 | $36.76 |
| 2002 | +76.29% | $12.06 | $21.26 |
| 2001 | +76.22% | $6.84 | $12.06 |
| 2000 | -37.43% | $10.94 | $6.84 |
| 1999 | -18.41% | $13.41 | $10.94 |
| 1998 | +16.89% | $11.47 | $13.41 |
| 1997 | -23.54% | $15.00 | $11.47 |
| 1996 | +21.83% | $12.31 | $15.00 |
| 1995 | +183.45% | $4.34 | $12.31 |
| 1994 | +39.00% | $3.12 | $4.34 |
| 1993 | -40.12% | $5.22 | $3.12 |
Valuation
BSX currently trades at a trailing P/E ratio of 35.6, which is considered high relative to the broader market. The forward P/E of 17.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 4.2. The price-to-sales ratio is 5.1.
Dividends
Boston Scientific Corporation does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
BSX has a beta of 0.70, indicating it is less volatile than the overall market. The stock's 52-week range is $67.56 to $109.50, and it currently trades near its 52-week low.
Analyst Ratings
Based on 33 analyst opinions, BSX has a consensus "strong_buy" rating. The average price target of $103.82 suggests 50.2% upside from current levels.
Frequently Asked Questions
What does Boston Scientific Corporation do? ▼
Boston Scientific Corporation is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Marlborough, United States.
What sector is BSX in? ▼
BSX operates in the Healthcare sector, specifically in the Medical Devices industry.
When did BSX go public? ▼
Boston Scientific Corporation went public in 1992, making it a 34-year-old public company as of 2026.
How much would $1,000 invested in BSX 5 years ago be worth today? ▼
A $1,000 investment in BSX five years ago would be worth approximately $1,758 today, representing a 75.8% return.
Does BSX pay dividends? ▼
No, Boston Scientific Corporation does not currently pay a dividend. The company reinvests its earnings into growth.
What is BSX's market cap? ▼
Boston Scientific Corporation has a market capitalization of $103 billion, classifying it as a large-cap company.
What is BSX's P/E ratio? ▼
BSX has a trailing P/E ratio of 35.6 and a forward P/E of 17.7, which measures how much investors are paying per dollar of earnings.
Is BSX a buy, hold, or sell? ▼
Based on 33 opinions, BSX has a consensus "strong_buy" rating. The average price target is $103.82.
Last updated: 3/14/2026